{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"TP53, a tumor suppressor in the DNA damage pathway, is the most frequently mutated gene in cancer.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":"LEVEL_Px1",
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"09/28/2022",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "31776133",
        "25584008",
        "26181206",
        "15037740"
      ]
    },
    "description":"The TP53 R273H mutation is located in the protein's DNA binding domain. This mutation has been found in triple-negative breast cancer and Li-Fraumeni syndrome (PMID: 31776133, 25584008). Expression of this mutant resulted in cell survival by activating AKT signaling and suppressing the expression of BCL-modifying factor (BMF) (PMID: 26181206). Expression of this mutant in TP53-null cells resulted in decreased transactivation of p53 target genes, as measured by a luciferase reporter assay (PMID: 25584008, 15037740). Expression of this mutation in osteosarcoma and breast cancer cell lines demonstrated that it is inactivating as measured by moderately increased cell proliferation and failure to suppress colony growth compared to wildtype (PMID: 25584008, 31776133).",
    "knownEffect":"Loss-of-function"
  },
  "oncogenic":"Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "25412851",
        "25860933"
      ],
      "tumorType":{
        "children":{},
        "code":"AMLMRC",
        "color":"LightSalmon",
        "id":17,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Leukemia",
          "tumorForm":"LIQUID"
        },
        "name":"AML with Myelodysplasia-Related Changes",
        "parent":"AML",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "22186996",
        "18596741"
      ],
      "tumorType":{
        "children":{},
        "code":"AML",
        "color":"LightSalmon",
        "id":527,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Leukemia",
          "tumorForm":"LIQUID"
        },
        "name":"Acute Myeloid Leukemia",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "25412846",
        "25952993"
      ],
      "tumorType":{
        "children":{},
        "code":"TMN",
        "color":"LightSalmon",
        "id":418,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Leukemia",
          "tumorForm":"LIQUID"
        },
        "name":"Therapy-Related Myeloid Neoplasms",
        "parent":"AML",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "23243274",
        "24004666",
        "20697090",
        "19188171",
        "24652989"
      ],
      "tumorType":{
        "children":{},
        "code":"CLLSLL",
        "color":"LimeGreen",
        "id":533,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
        "parent":"MBN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "21714648",
        "25092778",
        "24220272"
      ],
      "tumorType":{
        "children":{},
        "code":"MDS",
        "color":"LightSalmon",
        "id":355,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Myelodysplastic Syndromes",
          "tumorForm":"LIQUID"
        },
        "name":"Myelodysplastic Syndromes",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "24478400",
        "29296692",
        "22887079"
      ],
      "tumorType":{
        "children":{},
        "code":"ET",
        "color":"LightSalmon",
        "id":695,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Myeloproliferative Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Essential Thrombocythemia",
        "parent":"MPN",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "25516983",
        "22052707",
        "22887079"
      ],
      "tumorType":{
        "children":{},
        "code":"MPN",
        "color":"LightSalmon",
        "id":185,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Myeloproliferative Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Myeloproliferative Neoplasms",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "25516983",
        "22052707",
        "22887079"
      ],
      "tumorType":{
        "children":{},
        "code":"PMF",
        "color":"LightSalmon",
        "id":632,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Myeloproliferative Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Primary Myelofibrosis",
        "parent":"MPN",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px3",
      "pmids":[
        "8639789",
        "7579380",
        "28819011",
        "24684350",
        "26022239"
      ],
      "tumorType":{
        "children":{},
        "code":"MCL",
        "color":"LimeGreen",
        "id":586,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Mantle Cell Lymphoma",
        "parent":"MBN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "prognosticSummary":"",
  "query":{
    "alteration":"R273H",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":7157,
    "hgvs":"17:g.7673802C>T",
    "hugoSymbol":"TP53",
    "id":null,
    "proteinEnd":273,
    "proteinStart":273,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The TP53 R273H mutation is known to be oncogenic.",
  "vus":false
}